Sort
82,697 grants matching “vaccine development”
Protective Human Monoclonal Antibodies to HIV-1
$735,382Susan B Zolla-Pazner · New York University School Of Medicine · R01 · FY2008 · HL
Merkel cell polyomavirus HLA class I epitopes for generating therapeutic T cell-based cancer immunotherapy
$735,360Derin B Keskin · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Evaluation of an optimized intervention to prevent early substance use among American Indian youth: Examination of expanded impacts on youth and parents
$735,338Nancy Rumbaugh Whitesell · University Of Colorado Denver · R37 · FY2025 · DA
HIV-specific ex-vivo expanded T cell therapy (HXTC) to Deplete the Latent Reservoir of Persistent HIV Infection
$735,324David M. Margolis · Univ Of North Carolina Chapel Hill · R01 · FY2020 · HL
HIV-specific ex-vivo expanded T cell therapy (HXTC) to Deplete the Latent Reservoir of Persistent HIV Infection
$735,324David M. Margolis · Univ Of North Carolina Chapel Hill · R01 · FY2019 · HL
Identification and Characterization of Entry Factors Critical for Rift Valley Fever Virus Infection and Pathogenesis
$735,323Gaya K. Amarasinghe · Washington University · R01 · FY2024 · AI
CHARACTERIZATION OF HIV-1 ANTIBODY RESPONSES IN CHRONICALLY INFECTED WOMEN
$735,297Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R01 · FY2013 · AI
Developmental Exposures to Arsenic: Pneumonia, Immunity, and Microbiomes (DEAPIM)
$735,292Muhammad F Parvez · Columbia University Health Sciences · R01 · FY2023 · ES
Cellular Immune Responses to RSV infection in Mice
$735,184Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
The Functional Significance of CTL Escape
$735,158David I Watkins · University Of Wisconsin-Madison · R37 · FY2008 · AI
Expanded Phase II Trial of Carraguard for Prevention of HPV Infection
$735,147Mark H. Einstein · Albert Einstein College Of Medicine · R01 · FY2013 · CA
Development of a lyophilized intradermal/intranasal ricin vaccine
$735,115Ellen S Vitetta · Ut Southwestern Medical Center · U01 · FY2010 · AI
Prevention of Primary HCMV Infection by Vaccinating against HCMV-Encoded IL-10
$735,112Peter A Barry · University Of California At Davis · R01 · FY2015 · AI
Unraveling the molecular mechanisms of innate immune memory in humans
$735,078Luis Bruno Barreiro · University Of Chicago · R01 · FY2025 · AI
Extent and Significance of Bacterial DNA Integrations in the Human Cancer Genome
$735,063Julie Dunning Hotopp · University Of Maryland Baltimore · R01 · FY2017 · CA
Experimental human infection with isogenic mutants of Neisseria gonorrhoeae
$735,041Marcia Metzgar Hobbs · Univ Of North Carolina Chapel Hill · U01 · FY2017 · AI
Small Molecule Inhibitors Against 3C-Like Protease of SARS-CoV-2
$735,037Kyeong-Ok Chang · Kansas State University · R01 · FY2023 · AI
Small Molecule Inhibitors Against 3C-Like Protease of SARS-CoV-2
$735,037Kyeong-Ok Chang · Kansas State University · R01 · FY2022 · AI
A clinical process support system for primary care to address family stress
$735,013Barbara Howard · Total Child Health, Inc. · R44 · FY2017 · HD
Vaccines and therapies against botulism
$734,988Joseph T. Barbieri · University Of Chicago · U54 · FY2011 · AI
Antibody Landscape following Human Norovirus Infection and Vaccination
$734,952Ralph S Baric · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI
Small Molecule Protease Inhibitors against MERS-CoV
$734,924Kyeong-Ok Chang · Kansas State University · R01 · FY2019 · AI
Core C
$734,821Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2019 · AI
Childhood infection and prevention of obesity
$734,798Julie Parsonnet · Stanford University · R01 · FY2012 · HD
Fogarty AIDS International Training and Research Program (AITRP)
$734,715Chris Beyrer · Johns Hopkins University · D43 · FY2012 · TW